234 related articles for article (PubMed ID: 34710372)
41. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.
Mouillet-Richard S; Nishida N; Pradines E; Laude H; Schneider B; Féraudet C; Grassi J; Launay JM; Lehmann S; Kellermann O
J Biol Chem; 2008 Aug; 283(35):23782-90. PubMed ID: 18617522
[TBL] [Abstract][Full Text] [Related]
42. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
43. Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity.
Wei X; Roettger Y; Tan B; He Y; Dodel R; Hampel H; Wei G; Haney J; Gu H; Johnstone BH; Liu J; Farlow MR; Du Y
J Biol Chem; 2012 Apr; 287(16):12858-66. PubMed ID: 22362783
[TBL] [Abstract][Full Text] [Related]
44. Subcellular distribution of the prion protein in sickness and in health.
Godsave SF; Peters PJ; Wille H
Virus Res; 2015 Sep; 207():136-45. PubMed ID: 25683509
[TBL] [Abstract][Full Text] [Related]
45. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
[TBL] [Abstract][Full Text] [Related]
46. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
[TBL] [Abstract][Full Text] [Related]
47. Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.
Khalifé M; Reine F; Paquet-Fifield S; Castille J; Herzog L; Vilotte M; Moudjou M; Moazami-Goudarzi K; Makhzami S; Passet B; Andréoletti O; Vilette D; Laude H; Béringue V; Vilotte JL
J Virol; 2016 Feb; 90(3):1638-46. PubMed ID: 26608316
[TBL] [Abstract][Full Text] [Related]
48. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
[TBL] [Abstract][Full Text] [Related]
49. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region.
Perera WS; Hooper NM
Curr Biol; 2001 Apr; 11(7):519-23. PubMed ID: 11413003
[TBL] [Abstract][Full Text] [Related]
50. Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells.
Daude N; Lehmann S; Harris DA
J Biol Chem; 1997 Apr; 272(17):11604-12. PubMed ID: 9111077
[TBL] [Abstract][Full Text] [Related]
51. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
52. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
53. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
[TBL] [Abstract][Full Text] [Related]
54. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
[TBL] [Abstract][Full Text] [Related]
55. Protein misfolding cyclic amplification of prions.
Saunders SE; Bartz JC; Shikiya RA
J Vis Exp; 2012 Nov; (69):. PubMed ID: 23168797
[TBL] [Abstract][Full Text] [Related]
56. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
57. Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion.
Burke CM; Mark KMK; Walsh DJ; Noble GP; Steele AD; Diack AB; Manson JC; Watts JC; Supattapone S
PLoS Pathog; 2020 Sep; 16(9):e1008875. PubMed ID: 32898162
[TBL] [Abstract][Full Text] [Related]
58. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
59. Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein.
Imamura M; Kato N; Yoshioka M; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
J Virol; 2011 Mar; 85(6):2582-8. PubMed ID: 21228241
[TBL] [Abstract][Full Text] [Related]
60. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]